Vocational School of Health Services, Inonu University, Malatya, Turkey.
Physiology Department, Inonu University Faculty of Medicine, Malatya, Turkey.
Biotech Histochem. 2023 Nov;98(5):314-325. doi: 10.1080/10520295.2023.2187460. Epub 2023 Mar 22.
Diabetes mellitus (DM) is a chronic disease at all ages including childhood and puberty. Failure to treat DM can cause retinopathy, nephropathy and neuropathy. Endocrine and metabolic changes during the pubertal period complicate management of DM. Noopept is a cognitive enhancer that exhibits antidiabetic properties. We investigated the effect of noopept on the histopathology of the cornea, retina, kidney and pancreas in pubertal diabetic rats. We allocated 60 prepubertal male rats randomly into six groups of 10: untreated control (C), DM control (DC), noopept control (NC), DM + noopept (D + N), DM + insulin (D + I) and DM + insulin + noopept (D + I + N). DM was induced by streptozotocin in the DC, D + N, D + I and D + I + N groups. Noopept was administered to the NC, D + N and D + I + N groups; insulin was administered to the D + I and D + I + N groups for 14 days. On day 18 of the experiment, animals were sacrificed and eyes, kidneys and pancreata were excised for histological investigation. Renal tubule diameter and corneal and retinal thickness were increased significantly in DC groups compared to the control group. The D + I, D + N and D + I + N groups exhibited fewer DM induced pathological changes than the DC group. The D + I + N group exhibited no significant differences in renal tubule diameter and corneal and retinal thickness compared to the DC group. Our findings suggest that noopept is protective against DM end organ complications in streptozotocin induced diabetic pubertal rats.
糖尿病(DM)是一种在各个年龄段都会发生的慢性疾病,包括儿童和青春期。如果不治疗糖尿病,可能会导致视网膜病变、肾病和神经病变。青春期的内分泌和代谢变化会使糖尿病的管理变得复杂。诺啡肽是一种具有抗糖尿病作用的认知增强剂。我们研究了诺啡肽对青春期糖尿病大鼠角膜、视网膜、肾脏和胰腺组织病理学的影响。我们将 60 只未成熟雄性大鼠随机分为 6 组,每组 10 只:未处理对照组(C)、糖尿病对照组(DC)、诺啡肽对照组(NC)、糖尿病+诺啡肽组(D+N)、糖尿病+胰岛素组(D+I)和糖尿病+胰岛素+诺啡肽组(D+I+N)。DC、D+N、D+I 和 D+I+N 组用链脲佐菌素诱导糖尿病。NC、D+N 和 D+I+N 组给予诺啡肽;D+I 和 D+I+N 组给予胰岛素,共 14 天。实验第 18 天,处死动物,取出眼睛、肾脏和胰腺进行组织学检查。与对照组相比,DC 组的肾小管直径以及角膜和视网膜厚度显著增加。与 DC 组相比,D+I、D+N 和 D+I+N 组的糖尿病诱导的病理变化较少。与 DC 组相比,D+I+N 组的肾小管直径以及角膜和视网膜厚度无显著差异。我们的研究结果表明,诺啡肽可预防链脲佐菌素诱导的青春期糖尿病大鼠的糖尿病终末器官并发症。